A detailed history of Lpl Financial LLC transactions in Clene Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 29,607 shares of CLNN stock, worth $9,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,607
Previous 19,607 51.0%
Holding current value
$9,770
Previous $5,000 140.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.28 - $0.53 $2,800 - $5,300
10,000 Added 51.0%
29,607 $12,000
Q2 2023

Jul 31, 2023

BUY
$0.78 - $1.22 $15,293 - $23,920
19,607 New
19,607 $17,000

Others Institutions Holding CLNN

About Clene Inc.


  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $21M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.